ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 552

Inhibitor Of Differentiation 3, A Transcription Factor Regulates Susceptibility To Kidney Disease

Dominika Nackiewicz1, Ani Manichaikul2, Barbara Szczerba3, Paromita Dey3, Stephen Rich2, Coleen McNamara4, Umesh Deshmukh1 and Harini Bagavant3, 1Medicine, University of Virginia, Charlottesville, VA, 2Center for Public Genomics, University of Virginia, Charlottesville, VA, 3Department of Medicine, University of Virginia, Charlottesville, VA, 4University of Virginia, Charlottesville, VA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Glomerulonephritis and transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Responses of renal cells to pathogenic stimuli play an important role in dictating susceptibility to kidney disease.  Inhibitor of differentiation 3, ID3, is a member of the basic helix loop helix transcription factor family and is expressed in multiple cell types including glomerular mesangial cells.  We have previously reported that a genetic deficiency of ID3, leads to mesangio-proliferative glomerulonephritis in spontaneously hyperlipidemic Apolipoprotein E knockout (Apoe-/-) mice. In the present study, we investigated the mechanisms of ID3 related glomerular disease in hyperlipidemia and studied its relevance in humans. Influence of ID3 on immune mediated glomerulonephritis was also studied.

Methods:

To study whether ID3 deficiency was sufficient for hyperlipidemic glomerulonephritis, C57BL/6 mice that were either ID3 sufficient wild type (WT) or ID3 deficient (Id3-/- ) mice were fed a high fat western diet and evaluated for different parameters of kidney disease. To investigate the potential mechanism of action, primary mesangial cell lines were generated from both mouse strains and stimulated with oxidized phospholipids. Cytokines and chemokines produced were measured by multiplex assays, ELISA, and QPCR.  To study the relevance of ID3 in human disease, the association between ID3 single nucleotide polymorphisms (SNPs) and kidney disease was studied in participants in the Multi-Ethnic Study of Atherosclerosis (MESA) and the influence of dyslipidemia on this association was investigated.  As an additional model of kidney disease, WT and Id3-/- mice were injected with sheep anti-mouse glomerular basement membrane serum to induce immune mediated glomerular injury, and development of proteinuria was studied.

Results:

Id3-/- mice on a western diet developed accelerated proteinuria and mesangio-proliferative glomerulonephritis. In vitro, Id3-/- glomerular mesangial cell lines produced higher levels of the monocyte chemoattractant, CXCL1 in response to oxidized phospholipids compared to WT controls. This was consistent with the rapid increase in glomerular CXCL1 expression followed by glomerular macrophage infiltration in Id3-/- mice fed a western diet. In humans, an analysis of MESA participants across three ethnic groups showed that of six tagging ID3 SNPs, the T allele of a non-synonymous, functional SNP rs11574 showed a significant association with decreased urinary albumin creatinine ratios in Caucasians (P=0.012). This association was even stronger in participants carrying small low density lipoprotein particles (p=0.0024).  This suggests the hypothesis that in the presence of lipid abnormalities, a change in ID3 influences kidney disease.  The significance of functional ID3 in other forms of glomerular injury of kidney disease was further demonstrated in immune mediated nephrotoxic nephritis where Id3-/- mice developed severe and sustained proteinuria compared to WT mice.

 

Conclusion:

A functional ID3 may regulate susceptibility to kidney disease and prevent glomerular injury by regulating local chemokine production and inflammatory cell recruitment.


Disclosure:

D. Nackiewicz,
None;

A. Manichaikul,
None;

B. Szczerba,
None;

P. Dey,
None;

S. Rich,
None;

C. McNamara,
None;

U. Deshmukh,
None;

H. Bagavant,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inhibitor-of-differentiation-3-a-transcription-factor-regulates-susceptibility-to-kidney-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology